{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:39:47Z","timestamp":1791578387319,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["20210101442JC"],"award-info":[{"award-number":["20210101442JC"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.intimp.2024.112964","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T15:32:22Z","timestamp":1724167942000},"page":"112964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effects of curcumin nanoparticles on the proliferation and migration of human ovarian cancer cells assessed through the NF-\u03baB\/PRL-3 signaling pathway"],"prefix":"10.1016","volume":"141","author":[{"given":"Shuyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9303-9382","authenticated-orcid":false,"given":"Zanhui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112964_b0005","article-title":"Anti-angiogenesis maintenance therapy in newly diagnosed and relapsed ovarian cancer: a meta-analysis of phase III randomized controlled trials","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112964_b0010","article-title":"Clinical significance of screening differential metabolites in ovarian cancer tissue and ascites by LC\/MS","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112964_b0015","article-title":"Identifying the effect of celastrol against ovarian cancer with network pharmacology and in vitro experiments","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112964_b0020","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.3390\/jcm9092967","article-title":"Epithelial ovarian cancer and the immune system: biology, interactions, challenges and potential advances for immunotherapy","volume":"9","author":"Macpherson","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.112964_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/ijo.2021.5233","article-title":"A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer","volume":"59","author":"Falzone","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.intimp.2024.112964_b0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3390\/medicina59030544","article-title":"Ovarian cancer-insights into platinum resistance and overcoming it","volume":"59","author":"Havasi","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.intimp.2024.112964_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3892\/or.2022.8293","article-title":"Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer","volume":"47","author":"Yang","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2024.112964_b0040","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.3390\/cancers14246246","article-title":"Mechanisms of drug resistance in ovarian cancer and associated gene targets","volume":"14","author":"Alatise","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2024.112964_b0045","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3390\/ijms24031973","article-title":"Predicting prognosis and platinum resistance in ovarian cancer: role of Immunohistochemistry biomarkers","volume":"24","author":"Atallah","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112964_b0050","article-title":"Hotspots and frontiers in inflammatory tumor microenvironment research: a scientometric and visualization analysis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112964_b0055","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.3390\/cells11213473","article-title":"Curcumin reprograms TAMs from a protumor phenotype towards an antitumor phenotype via inhibiting MAO-A\/STAT6 pathway","volume":"11","author":"Jiang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112964_b0060","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/etm.2017.4568","article-title":"Celastrol inhibits migration and invasion through blocking the NF-\u03baB pathway in ovarian cancer cells","volume":"14","author":"Wang","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2024.112964_b0065","doi-asserted-by":"crossref","first-page":"41421","DOI":"10.18632\/oncotarget.9404","article-title":"Apigenin inhibits NF-\u03baB and snail signaling, EMT and metastasis in human hepatocellular carcinoma","volume":"7","author":"Qin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112964_b0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112964_b0075","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.18632\/oncotarget.23787","article-title":"Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor","volume":"9","author":"McQueeney","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2024.112964_b0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.04.018","article-title":"Curcumin effectively inhibits oncogenic NF-\u03baB signaling and restrains stemness features in liver cancer","volume":"63","author":"Marquardt","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2024.112964_b0085","doi-asserted-by":"crossref","first-page":"24675","DOI":"10.1038\/srep24675","article-title":"Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine\/NF-\u03baB signalling pathway","volume":"6","author":"Ruiz de Porras","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2024.112964_b0090","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.3390\/ijms22147645","article-title":"Curcumin attenuates environment-derived osteoarthritis by Sox9\/NF-\u03baB signaling axis","volume":"22","author":"Buhrmann","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112964_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/biom9020056","article-title":"Formulations of curcumin nanoparticles for brain diseases","volume":"9","author":"Del Prado-Audelo","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2024.112964_b0100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10856-021-06593-9","article-title":"Polyethylene glycol triggers the anti-cancer impact of curcumin nanoparticles in sw-1736 thyroid cancer cells","volume":"32","author":"Hosseinzadeh","year":"2021","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.intimp.2024.112964_b0105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/molecules25030689","article-title":"Curcumin delivery mediated by bio-based nanoparticles: a review","volume":"25","author":"Nasery","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112964_b0110","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/molecules25092244","article-title":"Formulation, characterization and biological activity screening of sodium alginate-gum arabic nanoparticles loaded with curcumin","volume":"25","author":"Hassani","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112964_b0115","doi-asserted-by":"crossref","first-page":"3012198","DOI":"10.1155\/2020\/3012198","article-title":"In vitro evaluation of curcumin-encapsulated chitosan manoparticles against feline infectious peritonitis virus and pharmacokinetics study in cats","volume":"2020","author":"Ng","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.intimp.2024.112964_b0120","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.3390\/nu14235192","article-title":"Improved stability and in vitro anti-arthritis bioactivity of curcumin-casein nanoparticles by ultrasound-driven encapsulation","volume":"14","author":"Li","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.intimp.2024.112964_b0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41698-021-00154-7","article-title":"Dynamic roles of inflammasomes in inflammatory tumor microenvironment","volume":"5","author":"Jang","year":"2021","journal-title":"NPJ Precis, Oncol."},{"key":"10.1016\/j.intimp.2024.112964_b0130","doi-asserted-by":"crossref","first-page":"32594","DOI":"10.1073\/pnas.2004470117","article-title":"The ARF tumor suppressor targets PPM1G\/PP2C\u03b3 to counteract NF-\u03baB transcription tuning cell survival and the inflammatory response","volume":"117","author":"Hyder","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2024.112964_b0135","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1073\/pnas.1918167117","article-title":"The functional activity of E-cadherin controls tumor cell metastasis at multiple steps","volume":"117","author":"Na","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.intimp.2024.112964_b0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13046-023-02839-2","article-title":"Histone acetyltransferase CSRP2BP promotes the epithelial-mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin","volume":"42","author":"Yang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2024.112964_b0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-020-00275-8","article-title":"Identification of miR-515-3p and its targets, vimentin and MMP3, as a key regulatory mechanism in esophageal cancer metastasis: functional and clinical significance","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.112964_b0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.30802\/AALAS-CM-20-000116","article-title":"A review of principal studies on the development and treatment of epithelial ovarian cancer in the laying hen gallus gallus","volume":"71","author":"Pal","year":"2021","journal-title":"Comp. Med."},{"key":"10.1016\/j.intimp.2024.112964_b0155","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/cancers12123730","article-title":"CA125 and ovarian cancer: a comprehensive review","volume":"12","author":"Charkhchi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2024.112964_b0160","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/cancers14122885","article-title":"Current and emerging methods for ovarian cancer screening and diagnostics: a comprehensive review","volume":"14","author":"Liberto","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.intimp.2024.112964_b0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13048-023-01151-z","article-title":"Mechanisms of ovarian aging in women: a review","volume":"16","author":"Wang","year":"2023","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.intimp.2024.112964_b0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/ijms21010337","article-title":"Curcumin can decrease tissue inflammation and the severity of HSV-2 infection in the female reproductive mucosa","volume":"21","author":"Vitali","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112964_b0175","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.3390\/molecules26247658","article-title":"The potential role of curcumin in modulating the master antioxidant pathway in diabetic hypoxia-induced complications","volume":"26","author":"Ghareghomi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.112964_b0180","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/15384047.2018.1550567","article-title":"Antitumor effect of curcumin liposome after transcatheter arterial embolization in VX2 rabbits","volume":"20","author":"Zhang","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.intimp.2024.112964_b0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2024.112964_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656908","article-title":"The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment","volume":"12","author":"Laha","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112964_b0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2024.112964_b0200","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3892\/or.2016.5030","article-title":"PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K\/Akt signaling pathway by regulating PTEN","volume":"36","author":"Xiong","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2024.112964_b0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.canlet.2016.07.017","article-title":"PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion","volume":"380","author":"Gari","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2024.112964_b0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3892\/or.2012.2080","article-title":"Curcumin inhibits LPS-induced EMT through downregulation of NF-\u03baB-Snail signaling in breast cancer cells","volume":"29","author":"Huang","year":"2013","journal-title":"Oncol. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924014851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924014851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T17:36:41Z","timestamp":1731087401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924014851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":42,"alternative-id":["S1567576924014851"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112964","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of curcumin nanoparticles on the proliferation and migration of human ovarian cancer cells assessed through the NF-\u03baB\/PRL-3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112964"}}